Owed CERS for a bit Their management team cannot get out its own way...
2 patients experienced durable objective responses including a complete response in Hodgkin lymphoma 18.9+ months. Hmm, I would say that is good.
The most amazing thing about the loss today is that Gugg recommended today with a $35 price target. Glowing report that urge people to read if they can. Max
Damn, I was hoping the next deal was with CLDX. Getting increasing frustrated that BMY is not choosing to collaborate with CLDX. Nice deal for Five Prime shareholders.
Worst president ever.....not even close. Makes Carter look like FDR.
Think they had to shore up their institutional support a bit. Rumor was First Trust sold about 20% of their position and that has contributed to the SP slide.
Sentiment: Strong Buy
Curious to see the volume today and see if institutions want CLDX on their portfolio holdings for quarter end. Then again, clearly they have been sellers this quarter.